HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - s
1414
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Neutralizing Monoclonal Antibodie
s
Against West Nile Virus
We
s
t Nile virus (WNV) is a mosquito-borne flavivirus that can cause fever and, in some cases, severe neurologic disease. There is no approved human vaccine or specific antiviral treatment for WNV. Researchers at NIAID's Vaccine Research Center (VRC), working with collaborators at Sheba Medical Center under the PREMISE program, identified...
Published: 4/24/2026
|
Updated: 4/24/2026
|
Inventor(s):
Daniel Douek
,
Chaim
S
chramm
,
Ananda Chowdhury
,
Parker Dabb
s
,
Lu Wang
,
Leonid
S
erebryannyy
,
Theodore Pier
s
on
,
Kimberly Dowd
,
Laura Vanblargan
,
Katherine Burgoma
s
ter
,
David Gordon
,
Yuxiang Wang
,
Yaniv Lu
s
tig
,
Yael Ottolenghi
,
Dror Harat
s
,
S
arah Smith (Kerscher)
Keywords(s):
Category(s):
Application
,
Re
s
earchProducts > Virus/Bacteria
,
Re
s
earchProducts
,
Re
s
earchProducts > Antibodies
,
TherapeuticArea
,
Application > Diagno
s
tics
Neutralizing Antibodie
s
Against West Nile Virus
We
s
t Nile virus (WNV) is a mosquito-borne virus that can cause severe disease affecting the brain and nervous system, especially in older adults and people with weakened immune systems. There is no approved human vaccine or specific antiviral treatment for WNV. Researchers at NIAID’s Vaccine Research Center (VRC), together with collaborators...
Published: 4/23/2026
|
Updated: 4/22/2026
|
Inventor(s):
Theodore Pier
s
on
,
Kimberly Dowd
,
Daniel Douek
,
Dror Harat
s
,
Yael Ottolenghi
,
Gili Regev-Yochay
,
Yaniv Lu
s
tig
Keywords(s):
Category(s):
TherapeuticArea
,
Application > Vaccine
s
,
Application
,
Application > Diagno
s
tics
,
Re
s
earchProducts
,
Re
s
earchProducts > Virus/Bacteria
Method
s
To Regulate Metabolism For Treatment Of Neural Injuries and Neurodegeneration
De
s
cription of Technology: Axonal injury and subsequent neuronal death underpin the pathology of many neurological disorders from acute neural injuries (motor vehicle crashes, combat related injuries, traumatic brain injuries) to neurological diseases (multiple sclerosis, glaucoma). In the central nervous system (CNS), microglia help respond to CNS...
Published: 4/16/2026
|
Updated: 4/16/2026
|
Inventor(s):
Wei Li
,
Jingxing Ou
,
Tantai Zhao
Keywords(s):
Category(s):
Application > Therapeutic
s
,
Collaboration
S
ought > Collaboration
,
TherapeuticArea > Ear, No
s
e, & Throat
,
TherapeuticArea > Neurology
,
Collaboration
S
ought > Licensing
DNA Methylation-Ba
s
ed Cancer Diagnostics for Accurate Tumor Classification
S
ummary: The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a collection of T-cell receptors (TCRs) that specifically target the mutated KRAS antigen. This technology encompasses a DNA methylation–based diagnostic platform designed to improve the accuracy and consistency of cancer classification,...
Published: 4/23/2026
|
Updated: 4/10/2026
|
Inventor(s):
Kenneth Aldape
,
Ziedulla Abdullaev
,
Ru
s
tamzhon Turakulov
,
S
tefania Pittaluga
,
Mark Raffeld
,
Elaine Jaffe
,
Omkar
S
ingh
,
Antonio
s
Papanicolau-Sengos
Keywords(s):
Category(s):
Application > Diagno
s
tics
,
TherapeuticArea > Oncology
,
Collaboration
S
ought > Collaboration
,
Collaboration
S
ought > Licensing
Nucleopho
s
min 1 (NPM1) Mutation-Specific T Cell Receptors for Targeted Treatment of Acute Myeloid Leukemia
S
ummary: The NCI seeks research co-development partners or licensees for Nucleophosmin 1 (NPM1) Mutation-Specific T Cell Receptors for Targeted Treatment of Acute Myeloid Leukemia. Description of Technology: Acute myeloid leukemia (AML) is a rare form of blood cancer affecting myeloid stem and progenitor cells, associated with a poor prognosis...
Published: 4/10/2026
|
Updated: 4/10/2026
|
Inventor(s):
Vid Leko
,
Aidan Pur
s
ley
,
Kenichi Hanada
,
Zhiya Yu
,
Catherine Ade
,
Jame
s
Yang
Keywords(s):
Category(s):
Application > Therapeutic
s
,
TherapeuticArea > Oncology
,
Collaboration
S
ought > Collaboration
,
Collaboration
S
ought > Licensing
48-Po
s
ition Custom Deep Well Plate For In Vitro Equilibrium Dialysis at a 1:1 Sample to Buffer Volume Ratio
CDC
s
cientists have developed a new design for a multi-well dialysis microplate for equilibrium dialysis. The unique design accommodates a 1:1 buffer to sample ratio and provides additional room at the base of the well to enable optimal cartridge immersion and analyte diffusion. The microplate is readily adaptable into existing automated analytical...
Published: 4/10/2026
|
Updated: 4/8/2026
|
Inventor(s):
A
s
hley Ribera
,
Hui Zhou
,
Hubert Ve
s
per
Keywords(s):
Category(s):
Application > Diagno
s
tics
,
Application > Re
s
earch Materials
,
Collaboration
S
ought
,
TherapeuticArea
,
TherapeuticArea > Endocrinology
,
TherapeuticArea > Geriatric
s
,
TherapeuticArea > Hematology
,
TherapeuticArea > Ob
s
tetrics/Neo-Natal
,
TherapeuticArea > Reproductive Health
,
TherapeuticArea > Urology
Novel malaria vaccine candidate
s
comprising engineered nanoparticles
U
s
ing proteins derived from the malaria Plasmodium falciparum parasite, NIAID has developed three different nanoparticle platforms to serve as scaffolds for displaying multiple copies of malaria antigens in an organized, repetitive manner to enhance vaccine effectiveness. The first platform uses the pyridoxal 5’-phosphate (PLP) synthase protein...
Published: 3/23/2026
|
Updated: 3/23/2026
|
Inventor(s):
Niraj Tolia
,
Da
s
huang Shi
,
Vu Nguyen
,
Thayne Dickey
Keywords(s):
Category(s):
TherapeuticArea
,
Re
s
earchProducts
,
Collaboration
S
ought
,
Application > Vaccine
s
Gene Editing for ALPK1 p.Thr237Met
RO
S
AH syndrome is a rare genetic disease caused by a mutation in the human alpha kinase 1 (ALPK1) gene (p.Thr237Met), leading to vision loss, swollen optic nerves, dry mouth, enlarged spleen, and frequent headaches. Researchers in the Laboratory of Clinical Immunology and Microbiology (LCIM) at the National Institute of Allergy and Infectious Diseases...
Published: 3/26/2026
|
Updated: 3/23/2026
|
Inventor(s):
Chri
s
tina Kozycki
,
Colin
S
weeney
,
Uimook Choi
Keywords(s):
Category(s):
Application
,
Collaboration
S
ought
,
Re
s
earchProducts
,
TherapeuticArea
,
TherapeuticArea > Rare/Neglected Di
s
eases
Pigment Epithelium-Derived Factor Peptide
s
and Their Use for Treating Retinal Degeneration
S
ummary: The National Eye Institute (NEI) seeks research co-development partners and/or licensees for the development of an AAV2-based delivery system or an eyedrop formulation to deliver a Pigment Epithelium-Derived Factor (PEDF) peptide as a gene-agnostic approach to treating inherited retinal diseases. Description of Technology: Retinitis...
Published: 3/24/2026
|
Updated: 3/13/2026
|
Inventor(s):
S
. Patricia Becerra
,
Alexandra Bernardo-Colon
,
Valeria Marigo
,
Andrea Bighinati
Keywords(s):
Category(s):
Application > Therapeutic
s
,
TherapeuticArea > Ear, No
s
e, & Throat
,
TherapeuticArea > Ophthalmology
,
Collaboration
S
ought > Licensing
,
Collaboration
S
ought > Collaboration
S
ystems and Methods to Automatically Detect Ellipsoid Zone Loss in SD-OCT Imaging
S
ummary: The National Eye Institute (NEI) seeks research co-development partners and/or licensees for an automatic deep learning-based algorithm to detect and quantitate ellipsoid zone (EZ) loss in Spectral Domain Optical Coherence Tomography (SD-OCT) images. Description of Technology: The present disclosure generally relates a method of automatically...
Published: 4/23/2026
|
Updated: 3/11/2026
|
Inventor(s):
Wathudurage De
S
ilva
,
Catherine Cukra
s
Keywords(s):
Category(s):
Application >
S
oftware / Apps
,
TherapeuticArea
,
TherapeuticArea > Ear, No
s
e, & Throat
,
Collaboration
S
ought > Collaboration
,
Collaboration
S
ought > Licensing
1
2
3
4
5
6
7
8
9
10
...
Home
|
Search
|
RSS
|
Subscribe
© 2026. All Rights Reserved. Powered by
Inteum